Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma

Novartis Investigative Site, Balassagyarmat

Novartis Investigative Site, Miskolc

Novartis Investigative Site, Erpent

Novartis Investigative Site, Berlin

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Marburg

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Münster

Novartis Investigative Site, Pisa

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Plano

Novartis Investigative Site, Kingwood

Novartis Investigative Site, Le Kremlin-Bicêtre

Novartis Investigative Site, Toronto

Novartis Investigative Site, Trois-Rivières

Novartis Investigative Site, Cottbus

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Sakaidechō

Novartis Investigative Site, Sagamihara

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Habikino

Novartis Investigative Site, Kishiwada

Novartis Investigative Site, Chuo-ku

Novartis Investigative Site, Edogawa-ku

Novartis Investigative Site, Itabashi-ku

Novartis Investigative Site, Ōta-ku

Novartis Investigative Site, Ōta-ku

Novartis Investigative Site, Shinagawa-ku

Novartis Investigative Site, Toshima-ku

Novartis Investigative Site, Harderwijk

Novartis Investigative Site, Leiden

Novartis Investigative Site, Bojnice

Novartis Investigative Site, Liptovský Hrádok

Novartis Investigative Site, Nitra

Novartis Investigative Site, Zvolen